Celsion corp (CLSN)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
Current assets:
Cash and cash equivalents

5,746

6,875

8,522

6,013

3,575

13,353

3,371

12,753

2,285

11,444

2,685

3,629

4,469

2,624

4,184

12,307

14,310

9,265

7,574

11,950

7,614

12,686

4,558

9,597

4,606

5,718

13,170

6,020

20,366

14,991

8,318

11,708

9,122

20,145

11,132

5,380

1,138

Investment in debt securities - available for sale, at fair value

9,887

7,985

10,290

15,702

20,166

14,257

18,579

13,442

18,411

12,724

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investment securities available for sale, at fair value

-

-

-

-

-

-

-

-

-

-

0

0

0

1,680

4,515

2,160

0

10,799

16,772

18,778

22,396

24,173

39,047

40,171

47,255

37,156

32,038

42,706

25,202

8,037

14,229

12,287

15,471

-

10,276

133

395

Investment securities  available for sale

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,157

-

-

-

Accrued interest receivable on investment securities

22

21

26

65

78

68

76

56

67

54

0

0

0

4

4

0

0

26

24

51

37

210

206

291

339

212

251

206

283

65

133

-

-

243

-

-

-

Receivable on sale of net operating losses

1,819

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Advances and deposits on clinical programs and other current assets

1,401

1,352

1,271

1,271

1,040

451

224

89

89

89

89

109

141

89

326

500

371

89

404

684

624

200

686

486

620

111

118

118

131

246

807

-

-

758

-

-

-

Vendor reimbursements receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

116

173

-

-

-

-

-

-

Refundable income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

100

-

-

-

235

-

-

-

563

519

520

430

190

103

939

1,178

-

804

693

492

Other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

115

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

203

-

-

-

Total current assets

18,876

16,235

20,111

23,053

24,861

28,131

22,252

26,341

20,852

24,311

2,774

3,738

4,611

4,512

9,030

14,968

14,682

20,281

24,776

31,465

30,672

37,506

44,498

50,545

52,822

43,762

46,097

49,572

46,414

23,648

23,766

24,934

25,772

31,508

22,214

6,207

2,026

Property and equipment (at cost, less accumulated depreciation of $3,135,681 and $3,096,681, respectively)

374

405

430

386

299

184

166

192

175

175

142

256

370

462

543

657

756

854

954

1,009

1,105

1,170

1,043

850

747

832

947

1,022

1,039

1,114

1,007

1,049

908

782

583

479

378

Other assets:
Deferred tax asset

-

1,819

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

In-process research and development, net

15,736

15,736

15,736

15,736

15,736

15,736

15,736

20,246

20,246

20,246

20,246

22,766

22,766

22,766

-

-

-

24,210

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

1,976

1,976

1,976

1,976

1,976

1,976

1,976

1,976

1,976

1,976

1,976

1,976

1,976

1,976

1,976

1,976

1,976

1,976

1,976

1,976

1,976

1,976

1,976

1,938

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease right-of-use assets, net

1,339

1,431

1,521

1,609

1,695

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other intangible assets, net

284

340

397

454

511

568

625

681

738

795

852

909

966

1,022

-

-

-

1,591

-

-

-

-

-

25,801

18

-

22

24

26

-

30

31

33

35

37

39

43

Security deposit on letter of credit

-

-

-

-

-

-

-

-

-

-

0

0

100

100

100

100

100

100

-

-

-

150

-

-

-

200

-

-

-

250

-

-

-

250

250

-

0

Other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

8

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

358

-

-

-

Deferred financing fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

68

-

-

-

844

-

-

-

306

-

-

-

-

-

85

-

Deposits and other assets

349

333

390

370

315

258

155

70

8

8

8

8

8

-

8

10

12

14

142

152

216

21

236

423

1,120

31

364

395

477

38

605

520

322

72

99

76

76

Total other assets

19,685

21,637

20,022

20,147

20,235

18,539

18,493

22,975

22,970

23,026

23,083

25,660

25,817

25,874

27,886

27,888

27,890

27,892

27,927

27,939

28,005

28,017

28,029

28,181

1,139

1,075

386

420

503

595

635

551

356

-

387

202

119

Total assets

38,936

38,278

40,563

43,587

45,395

46,855

40,911

49,509

43,998

47,514

26,000

29,656

30,798

30,849

37,461

43,514

43,329

49,028

53,659

60,414

59,784

66,694

73,571

79,578

54,709

45,670

47,431

51,014

47,957

25,358

25,409

26,536

27,037

32,649

23,185

6,888

2,525

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable - trade

2,856

2,862

3,935

3,392

2,585

3,020

3,159

3,703

3,416

3,416

2,806

3,544

4,051

2,878

3,025

2,949

2,764

2,830

2,503

3,202

4,112

3,480

4,435

3,616

2,102

1,452

2,249

1,522

4,180

2,339

2,944

4,305

3,708

4,010

2,772

3,327

4,548

Other accrued liabilities

1,399

2,303

2,396

2,389

2,462

2,585

2,140

2,032

1,716

2,282

2,690

2,911

2,819

2,483

2,645

2,378

2,097

1,919

1,448

2,235

1,923

2,456

1,775

1,873

2,205

2,707

-

-

-

-

-

-

-

-

-

-

-

Other accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,394

1,782

1,097

1,254

2,715

1,890

2,611

2,031

1,776

1,688

2,124

Notes payable - current portion, net of deferred financing costs

2,276

1,840

579

-

-

-

-

-

-

-

0

0

1,471

2,560

3,593

4,578

4,201

4,073

3,977

3,865

3,756

3,654

2,700

1,776

439

10

1,944

1,904

1,883

1,410

945

493

78

110

88

120

123

Operating lease liability - current portion

398

387

377

366

344

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue - current portion

500

500

500

500

500

500

-

-

-

500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue - current portion

-

-

-

-

-

-

500

500

500

-

500

500

500

500

500

500

500

500

500

500

500

500

500

500

500

500

500

500

500

-

-

-

-

-

-

-

-

Total current liabilities

7,430

7,894

7,789

6,648

5,893

6,106

5,799

6,235

5,633

6,199

5,997

6,956

8,842

8,423

9,764

10,406

9,563

9,323

8,429

9,804

10,292

10,090

9,411

7,766

5,247

4,670

6,087

5,710

7,662

5,005

6,605

6,690

6,398

6,152

4,638

5,135

6,796

Earn-out milestone liability

5,758

5,717

5,818

5,904

5,777

8,907

8,970

13,085

12,808

12,538

12,518

13,764

13,471

13,188

14,477

13,815

14,224

13,921

13,622

13,905

13,835

13,663

13,877

13,877

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

318

275

398

494

-

3

5,252

4,733

3

4,283

1,417

536

88

166

290

665

248

Note payable, net of deferred financing costs

7,623

7,963

9,126

9,608

9,514

9,417

9,319

9,222

-

-

-

-

-

-

0

0

1,319

2,350

3,343

4,286

5,187

6,053

6,887

7,868

4,560

5,000

2,346

2,847

3,173

3,661

4,140

4,605

57

71

0

0

56

Operating lease liability - non-current portion

1,040

1,143

1,244

1,343

1,438

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue - non-current portion

875

1,000

1,125

1,250

1,375

1,500

1,625

1,750

1,875

2,000

2,125

2,250

2,375

2,500

2,625

2,750

2,875

3,000

3,125

3,250

3,375

3,500

3,625

3,750

3,875

4,000

4,125

4,250

4,375

-

-

-

-

-

-

-

-

Other liabilities - non-current

-

-

-

-

-

63

65

68

70

71

73

36

3

12

21

30

38

47

55

63

70

286

454

461

467

472

477

483

442

446

221

128

130

65

-

-

0

8% Series A Redeemable Convertible Preferred Stock, 100,000 shares authorized, 5,000 issued and 864 outstanding at June 30, 2011 (aggregate liquidation preference of $864,000 as of June 30, 2011) (Note 10)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

597

-

Total liabilities

22,728

23,719

25,104

24,755

23,999

25,994

25,780

30,362

20,387

20,809

20,713

23,007

24,692

24,123

26,888

27,002

28,020

28,642

28,575

31,309

33,080

33,869

34,654

34,218

14,150

14,146

18,290

18,025

15,656

13,397

12,385

11,959

6,675

6,455

4,928

6,399

7,100

Commitments and contingencies

-

-

-

-

-

-

-

0

0

-

0

0

0

0

0

0

0

0

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Stockholders' equity:
Preferred stock - $0.01 par value (100,000 shares authorized, and no shares issued or outstanding at March 31, 2020 and December 31, 2019)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

-

-

0

-

-

-

-

-

-

-

-

Common stock - $0.01 par value (112,500,000 shares authorized; 29,257,435 and 23,256,152 shares issued at March 31, 2020 and December 31, 2019, respectively, and 29,257,101 and 23,255,818 shares outstanding at March 31, 2020 and December 31, 2019, respectively)

292

232

220

210

196

188

179

177

177

172

83

59

554

22

260

258

234

233

231

230

200

200

200

-

-

137

-

-

-

-

-

-

-

-

-

-

-

Additional paid-in capital

311,570

304,885

-

-

-

294,393

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock, $0.01 par value; 75,000,000 shares authorized; 20,082,353 and 13,737,970 shares issued at June 30, 2014 and December 31, 2013, and 19,958,121 and 13,604,975 shares outstanding at June 30, 2014 and December 31, 2013, respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

200

173

-

137

618

514

84

354

338

338

338

273

204

140

Additional paid-in capital

-

-

302,704

300,549

297,231

-

294,162

293,549

289,810

288,408

262,389

258,104

252,176

248,168

246,401

245,972

240,282

239,668

238,864

238,644

230,627

229,778

229,447

228,944

217,535

203,139

197,082

190,963

190,743

170,957

158,121

153,867

153,531

153,237

139,139

114,957

99,316

Accumulated other comprehensive gain

3

42

34

94

86

29

20

-4

-33

-10

-

-

-

0

0

0

0

-3

-1

-4

-7

-16

-26

-11

-27

-44

-305

-213

-158

-126

-131

-315

-277

-276

-157

21

-18

Accumulated deficit

-295,573

-290,516

-287,414

-281,937

-276,032

-273,665

-279,145

-274,489

-266,258

-261,781

-257,101

-251,429

-246,539

-241,379

-235,673

-228,755

-224,024

-218,130

-212,489

-208,074

-202,252

-195,073

-188,501

-181,512

-174,744

-169,287

-165,302

-155,697

-156,118

-156,263

-142,620

-136,598

-130,472

-124,221

-118,090

-111,674

-100,938

Total stockholders' equity before treasury stock

16,293

14,644

15,544

18,916

21,481

20,946

15,216

19,232

23,695

26,789

5,372

6,733

6,191

6,811

10,989

17,475

16,492

21,767

26,605

30,797

28,568

34,889

41,120

47,621

42,936

33,945

31,611

35,669

34,981

14,652

15,724

17,292

23,120

29,077

21,165

3,509

-1,498

Treasury stock, at cost (334 shares at March 31, 2020 and December 31, 2019)

85

85

85

85

85

85

85

85

85

85

85

85

85

85

417

963

1,183

1,382

1,522

1,691

1,864

2,064

2,204

2,261

2,377

2,421

2,469

2,680

2,680

2,690

2,700

2,716

2,758

2,884

2,909

3,019

3,076

Total stockholders' equity

16,208

14,559

15,459

18,831

21,396

20,861

15,131

19,147

23,610

26,704

5,287

6,648

6,106

6,725

10,572

16,512

15,309

20,385

25,083

29,105

26,703

32,825

38,916

45,359

40,559

31,523

29,141

32,989

32,300

11,961

13,023

14,576

20,361

26,193

18,256

489

-4,575

Total liabilities and stockholders' equity

38,936

38,278

40,563

43,587

45,395

46,855

40,911

49,509

43,998

47,514

26,000

29,656

30,798

30,849

37,461

43,514

43,329

49,028

53,659

60,414

59,784

66,694

73,571

79,578

54,709

45,670

47,431

51,014

47,957

25,358

25,409

26,536

27,037

32,649

23,185

6,888

2,525